Molecular MR Imaging of Prostate Cancer

This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kader, Avan, Brangsch, Julia, Kaufmann, Jan O., Zhao, Jing, Mangarova, Dilyana B., Moeckel, Jana, Adams, Lisa C., Sack, Ingolf, Taupitz, Matthias, Hamm, Bernd, Makowski, Marcus R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822017/
https://www.ncbi.nlm.nih.gov/pubmed/33375045
http://dx.doi.org/10.3390/biomedicines9010001
_version_ 1783639542931128320
author Kader, Avan
Brangsch, Julia
Kaufmann, Jan O.
Zhao, Jing
Mangarova, Dilyana B.
Moeckel, Jana
Adams, Lisa C.
Sack, Ingolf
Taupitz, Matthias
Hamm, Bernd
Makowski, Marcus R.
author_facet Kader, Avan
Brangsch, Julia
Kaufmann, Jan O.
Zhao, Jing
Mangarova, Dilyana B.
Moeckel, Jana
Adams, Lisa C.
Sack, Ingolf
Taupitz, Matthias
Hamm, Bernd
Makowski, Marcus R.
author_sort Kader, Avan
collection PubMed
description This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.
format Online
Article
Text
id pubmed-7822017
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78220172021-01-23 Molecular MR Imaging of Prostate Cancer Kader, Avan Brangsch, Julia Kaufmann, Jan O. Zhao, Jing Mangarova, Dilyana B. Moeckel, Jana Adams, Lisa C. Sack, Ingolf Taupitz, Matthias Hamm, Bernd Makowski, Marcus R. Biomedicines Review This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size. MDPI 2020-12-22 /pmc/articles/PMC7822017/ /pubmed/33375045 http://dx.doi.org/10.3390/biomedicines9010001 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kader, Avan
Brangsch, Julia
Kaufmann, Jan O.
Zhao, Jing
Mangarova, Dilyana B.
Moeckel, Jana
Adams, Lisa C.
Sack, Ingolf
Taupitz, Matthias
Hamm, Bernd
Makowski, Marcus R.
Molecular MR Imaging of Prostate Cancer
title Molecular MR Imaging of Prostate Cancer
title_full Molecular MR Imaging of Prostate Cancer
title_fullStr Molecular MR Imaging of Prostate Cancer
title_full_unstemmed Molecular MR Imaging of Prostate Cancer
title_short Molecular MR Imaging of Prostate Cancer
title_sort molecular mr imaging of prostate cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822017/
https://www.ncbi.nlm.nih.gov/pubmed/33375045
http://dx.doi.org/10.3390/biomedicines9010001
work_keys_str_mv AT kaderavan molecularmrimagingofprostatecancer
AT brangschjulia molecularmrimagingofprostatecancer
AT kaufmannjano molecularmrimagingofprostatecancer
AT zhaojing molecularmrimagingofprostatecancer
AT mangarovadilyanab molecularmrimagingofprostatecancer
AT moeckeljana molecularmrimagingofprostatecancer
AT adamslisac molecularmrimagingofprostatecancer
AT sackingolf molecularmrimagingofprostatecancer
AT taupitzmatthias molecularmrimagingofprostatecancer
AT hammbernd molecularmrimagingofprostatecancer
AT makowskimarcusr molecularmrimagingofprostatecancer

Ejemplares similares